| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |